GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Saniona AB (OSTO:SANION) » Definitions » Gross Margin %

Saniona AB (OSTO:SANION) Gross Margin % : 74.77% (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Saniona AB Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Saniona AB's Gross Profit for the three months ended in Dec. 2023 was kr4.02 Mil. Saniona AB's Revenue for the three months ended in Dec. 2023 was kr5.37 Mil. Therefore, Saniona AB's Gross Margin % for the quarter that ended in Dec. 2023 was 74.77%.

Warning Sign:

Saniona AB gross margin has been in long-term decline. The average rate of decline per year is -1.4%.


The historical rank and industry rank for Saniona AB's Gross Margin % or its related term are showing as below:

OSTO:SANION' s Gross Margin % Range Over the Past 10 Years
Min: 51.16   Med: 70.72   Max: 98.03
Current: 69.96


During the past 12 years, the highest Gross Margin % of Saniona AB was 98.03%. The lowest was 51.16%. And the median was 70.72%.

OSTO:SANION's Gross Margin % is ranked better than
60.88% of 749 companies
in the Biotechnology industry
Industry Median: 60.63 vs OSTO:SANION: 69.96

Saniona AB had a gross margin of 74.77% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Saniona AB was -1.40% per year.


Saniona AB Gross Margin % Historical Data

The historical data trend for Saniona AB's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Saniona AB Gross Margin % Chart

Saniona AB Annual Data
Trend Jan14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 51.16 60.33 55.81 70.72 69.96

Saniona AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 68.48 52.22 70.57 71.82 74.77

Competitive Comparison of Saniona AB's Gross Margin %

For the Biotechnology subindustry, Saniona AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Saniona AB's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Saniona AB's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Saniona AB's Gross Margin % falls into.



Saniona AB Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Saniona AB's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=11.8 / 16.84
=(Revenue - Cost of Goods Sold) / Revenue
=(16.84 - 5.059) / 16.84
=69.96 %

Saniona AB's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=4 / 5.374
=(Revenue - Cost of Goods Sold) / Revenue
=(5.374 - 1.356) / 5.374
=74.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Saniona AB  (OSTO:SANION) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Saniona AB had a gross margin of 74.77% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Saniona AB Gross Margin % Related Terms

Thank you for viewing the detailed overview of Saniona AB's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Saniona AB (OSTO:SANION) Business Description

Traded in Other Exchanges
Address
Smedeland 26B, Glostrup, DNK, DK-2600
Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases and the treatment of pain. It develops a technology platform that enables the investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. The company product pipeline includes Tesomet, SAN711, Tesofensine, SAN903, and SAN2219.

Saniona AB (OSTO:SANION) Headlines

No Headlines